Achilles therapeutics to present at upcoming scientific congresses

London, oct. 01, 2021 (globe newswire) -- achilles therapeutics plc (nasdaq: achl), a clinical-stage biopharmaceutical company developing precision t cell therapies to treat solid tumors, will present an oral presentation at the 2021 european society for gene and cell therapy (esgct) congress being held in a virtual format from october 19-22, 2021, and two posters at the society for immunotherapy of cancer (sitc) 36th annual meeting being held in a hybrid format from november 10-14, 2021 online and in person in washington, dc.
ACHL Ratings Summary
ACHL Quant Ranking